loading

Avenue Therapeutics Inc Azioni (ATXI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31
Durata del periodo 3 mesi
Research and Development
Operating Income/Loss
Nonoperating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Basic Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
$100.09
price up icon 0.11%
$51.71
price up icon 0.66%
$28.49
price down icon 0.59%
$108.80
price down icon 0.95%
$150.00
price up icon 0.94%
biotechnology ONC
$322.37
price down icon 8.48%
Capitalizzazione:     |  Volume (24 ore):